Neurolymphomatosis detected by 18F-FDG PET/CT

 

Figure 1: 18F-FDG maximum intensity projections (MIP) demonstrated intensely increased 18F-FDG uptake in large paracaval and right common iliac lymphadenopathies (A), as well shown also by the fused corresponding PET/CT coronal slices (B).

 

Figure 2: Fused PET/CT axial slices demonstrated focal tracer uptake located in the right sacral plexus (A, arrow), also evident in the coronal fused PET/CT images (B, arrow)

Description:

A 56 year-old male, diagnosed with diffuse large-B-cell lymphoma (DLBCL), presenting intense lumbosacral pain with irradiation to right inferior limb, was submitted to PET/CT scan with 18F-FDG as a staging study.

On the PET/CT scan an intensely increased uptake of 18F-FDG was found in correspondence of the right sacral plexus, consistent with patient’s algic symptomatology. A subsequently performed MRI confirmed the diagnosis of neurolymphomatosis. Patient was submitted to chemotherapy.

 

Discussion:

Neurolymphomatosis (NL) is a rare and severe clinical condition, consisting in a nervous root dysfunction secondary to infiltration by lymphoma. NL is an important prognostic factor, since the response rate to chemotherapy is of about 80% with a variable long-term outcome.

NL diagnosis, especially through conventional contrast-enhanced CT, may be challenging. In this field, the role of PET/CT with 18F-FDG, although it is still to be defined with well-designed clinical studies, seems to be promising.

 

Reference

Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol. 2010;12(2):212–215. doi:10.1093/neuonc/nop021

 

This Case was kindly provided by:

Luca Filippi, MD
Dep. of Nuclear Medicine, “Santa Maria Goretti” Hospital,
Via Canova, 04100, Latina
Italy
Contact

More Cases

Case No. 19

Neuroendocrine tumor heterogeneity on hybrid imaging

Case No. 17

Intimal sarcoma of the right pulmonary artery: 18F-FDG PET/CT